Healthcare

Le succès d'un vaccin contre la COVID-19 est l'un des plus grands défis auxquels nous sommes confrontés au niveau mondial. Ce document explore les opportunités et les obstacles qui se présentent à nous.

The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.

Our new 27-country survey finds rising levels of satisfaction and trust in health services as the world battles against the coronavirus pandemic. Waiting times and lack of staff are the main challenges perceived by the public.

Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability.

As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?

Most do not expect any will be available before the end of year; fear of side effects is top reason for not wanting to take the vaccine.

Two in three support restricting number of in class days while experts question effectiveness.

Virtual care has gained increased importance during coronavirus, but will this bring about a permanent shift in remote healthcare.

The coronavirus pandemic continues to be the world’s greatest worry, but it is giving way to greater concern about unemployment in some countries.